| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
9,468.7150 | 9,097.6920 | 3,453.0030 | 1,952.4410 | 171.1690 |
|
Cost of Revenue
|
-4,199.3930 | -3,956.2860 | -2,373.3360 | -1,495.9240 | -241.9630 |
|
Gross Profit
|
5,269.3220 | 5,141.4060 | 1,079.6670 | 456.5170 | -70.7940 |
|
Selling, General and Administrative Expenses
|
-7,768.2930 | -7,384.5170 | -7,901.6950 | -6,926.2690 | -6,979.4160 |
|
Research and Development Expenses
|
-5,400.9090 | -4,983.3620 | -5,065.1810 | -6,940.6860 | -4,929.4270 |
| Other Income/Expense, Operating
|
0 | 3,000 | 0 | 1,455.1880 | 1,948.8720 |
|
Operating Income/Expenses
|
-13,169.2020 | -9,367.8790 | -12,966.8760 | -12,411.7670 | -9,959.9710 |
|
Total Operating Profit/Loss
|
-7,899.8800 | -4,226.4730 | -11,887.2090 | -11,955.2500 | -10,030.7650 |
| Total Net Finance Income/Expense
|
0 | -334.0630 | -228.9880 | 0 | 0 |
| Net Investment Income
|
305.4200 | 784.6700 | -327.0920 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
148.9960 | 170.4920 | 125.1790 | 95.7590 | 31.1520 |
|
Non-Operating Income/Expenses, Total
|
454.4160 | 621.0990 | -430.9010 | 95.7590 | 31.1520 |
|
Pretax Income
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
|
Net Income after Non-Controlling/Minority Interests
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
|
Net Income Available to Common Stockholders
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
|
Diluted Net Income Available to Common Stockholders
|
-7,445.4640 | -3,605.3740 | -12,318.1100 | -11,859.4910 | -9,999.6130 |
| Basic EPS
|
-0.90 | -0.54 | -2.76 | -3.90 | -3.78 |
| Diluted EPS
|
-0.97 | -0.54 | -2.76 | -3.90 | -3.78 |
|
Basic Weighted Average Shares Outstanding
|
8,469.4990 | 6,692.1460 | 4,460.3990 | 3,020.1850 | 2,666.4280 |
|
Diluted Weighted Average Shares Outstanding
|
8,551.8210 | 6,692.1460 | 4,460.3990 | 3,020.1850 | 2,666.4280 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-7,445.4640 | -3,271.3110 | -12,089.1220 | -11,859.4910 | -9,999.6130 |
|
EBITDA
|
-7,208.5860 | -3,009.6320 | -11,842.3310 | -11,660.2250 | -9,880.9930 |
|
Normalized EBITDA
|
-6,101.2790 | -2,529.6940 | -10,170.7630 | -10,522.6250 | -8,933.7810 |
|
Normalized Income
|
-6,338.1570 | -3,125.4360 | -10,646.5420 | -10,721.8910 | -9,052.4010 |
|
Total Unusual Items
|
1,107.3070 | 479.9380 | 1,671.5680 | 1,137.6000 | 947.2120 |
|
Total Unusual Items Excluding Goodwill
|
1,107.3070 | 479.9380 | 1,671.5680 | 1,137.6000 | 947.2120 |
9/30/2022 - 3/15/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade